Abstract
Introduction: Pregabalin is a gamma-aminobutyric acid (GABA) analogue approved for the treatment of neuropathic pain, partial seizure and generalized anxiety disorder. As a GABA analogue, there is a raising concern regarding the abuse potential of this drug.
Case: We present a first case of pregabalin dependence in a 26-year-old woman without a previous history of illicit drug abuse.
Discussion: Physician should be aware about the addictive potential of pregabalin even in patients without a previous history of substance abuse.
Keywords: Bipolar disorder, pregabalin, substance abuse.
Current Drug Safety
Title:Pregabalin Dependence: A Case Report
Volume: 10 Issue: 2
Author(s): Athar Halaby, Sandra Abou Kassm and Wadih J. Naja
Affiliation:
Keywords: Bipolar disorder, pregabalin, substance abuse.
Abstract: Introduction: Pregabalin is a gamma-aminobutyric acid (GABA) analogue approved for the treatment of neuropathic pain, partial seizure and generalized anxiety disorder. As a GABA analogue, there is a raising concern regarding the abuse potential of this drug.
Case: We present a first case of pregabalin dependence in a 26-year-old woman without a previous history of illicit drug abuse.
Discussion: Physician should be aware about the addictive potential of pregabalin even in patients without a previous history of substance abuse.
Export Options
About this article
Cite this article as:
Halaby Athar, Kassm Abou Sandra and Naja J. Wadih, Pregabalin Dependence: A Case Report, Current Drug Safety 2015; 10 (2) . https://dx.doi.org/10.2174/1574886309666141022101956
DOI https://dx.doi.org/10.2174/1574886309666141022101956 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Imaging of Muscarinic Receptors in the Central Nervous System
Current Pharmaceutical Design Transient Receptor Potential Channels - Emerging Novel Drug Targets for the Treatment of Pain
Current Medicinal Chemistry The Potential Role of Pro-Inflammatory and Anti-Inflammatory Cytokines in Epilepsy Pathogenesis
Endocrine, Metabolic & Immune Disorders - Drug Targets Drug Delivery to CNS: Challenges and Opportunities with Emphasis on Biomaterials Based Drug Delivery Strategies
Current Pharmaceutical Design Expressed Emotion and Eating Disorders: An Updated Review
Current Psychiatry Reviews Homocysteine in Neurological Disease: A Marker or a Cause?
CNS & Neurological Disorders - Drug Targets Group I Metabotropic Receptor Neuroprotection Requires Akt and Its Substrates that Govern FOXO3a, Bim, and β-Catenin During Oxidative Stress
Current Neurovascular Research Method to Assess Interactivity of Drugs with Nonparallel Concentration Effect Relationships
Current Cancer Drug Targets Glutamate as a Modulator of Embryonic and Adult Neurogenesis
Current Topics in Medicinal Chemistry Erythropoietin: A Neuroprotective Agent in Cerebral Hypoxia, Neurodegeneration, and Epilepsy
Current Pharmaceutical Design Therapeutic Potential of Neurogenesis for Prevention and Recovery from Alzheimers Disease: Allopregnanolone as a Proof of Concept Neurogenic Agent
Current Alzheimer Research Prevalence of Cognitive Impairment and Dementia in Malays – Epidemiology of Dementia in Singapore Study
Current Alzheimer Research Structure Activity Relationships of Novel Antiepileptic Drugs
Current Medicinal Chemistry Serotonergic Drugs: Agonists/Antagonists at Specific Serotonergic Subreceptors for the Treatment of Cognitive, Depressant and Psychotic Symptoms in Alzheimer’s Disease
Current Pharmaceutical Design Synthesis, Molecular Modeling and Biological Evaluation of 5-arylidene-N,N-diethylthiobarbiturates as Potential α-glucosidase Inhibitors
Medicinal Chemistry Evaluation of Antioxidant Activity of Phytol Using Non- and Pre-Clinical Models
Current Pharmaceutical Biotechnology Herbal Medicines for Diabetes Management and its Secondary Complications
Current Diabetes Reviews Ion Channels as Important Targets for Antiepileptic Drug Design
Current Drug Targets Transglutaminase Activity as a Possible Therapeutical Target in Neurodegenerative Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Biochemical Markers for Brain Injury Monitoring in Children with or without Congenital Heart Diseases
CNS & Neurological Disorders - Drug Targets